Biocryst Pharmaceuticals (BCRX) EBT Growth (3y) (2013 - 2026)
Biocryst Pharmaceuticals (BCRX) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 21.00% |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.19% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 3.60% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -29.91% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 10.08% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 39.40% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.10 Bn | 214.41 Mn | 45.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.27% |
| Mar 31, 2026 | -139.21% |
| Dec 31, 2025 | 76.20% |
| Sep 30, 2025 | 31.92% |
| Jun 30, 2025 | 28.30% |
| Mar 31, 2025 | 26.21% |
| Dec 31, 2024 | -18.74% |
| Sep 30, 2024 | 38.85% |
| Jun 30, 2024 | 33.85% |
| Mar 31, 2024 | 18.33% |
| Dec 31, 2023 | 1.92% |
| Sep 30, 2023 | 8.07% |
| Jun 30, 2023 | -24.48% |
| Mar 31, 2023 | -11.91% |
| Dec 31, 2022 | -181.11% |
| Sep 30, 2022 | -2.80% |
| Jun 30, 2022 | -15.75% |
| Mar 31, 2022 | -32.94% |
| Dec 31, 2021 | 14.97% |
| Sep 30, 2021 | -24.83% |